POZZI, ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 1.575
EU - Europa 1.234
AS - Asia 833
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.646
Nazione #
US - Stati Uniti d'America 1.568
CN - Cina 749
IE - Irlanda 356
UA - Ucraina 264
DE - Germania 181
FI - Finlandia 177
SE - Svezia 78
SG - Singapore 61
GB - Regno Unito 54
IT - Italia 53
FR - Francia 28
NL - Olanda 20
BE - Belgio 12
CA - Canada 6
KR - Corea 6
IN - India 4
CO - Colombia 3
IR - Iran 3
PL - Polonia 3
VN - Vietnam 3
JP - Giappone 2
MK - Macedonia 2
RU - Federazione Russa 2
AT - Austria 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
LB - Libano 1
MX - Messico 1
OM - Oman 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
Totale 3.646
Città #
Dublin 356
Chandler 319
Jacksonville 313
Nanjing 211
Ashburn 131
Boardman 99
Beijing 84
Nanchang 82
Shenyang 64
Lawrence 61
Princeton 61
Hebei 57
Ann Arbor 55
Wilmington 55
Helsinki 54
Jiaxing 54
Piscataway 47
Changsha 43
Shanghai 43
Medford 39
Hangzhou 35
Singapore 35
Woodbridge 28
Tianjin 26
Milan 23
New York 21
Verona 15
Brussels 12
Fairfield 11
Kunming 11
Los Angeles 10
Seattle 8
Des Moines 7
Norwalk 7
Dearborn 6
Tappahannock 6
Washington 6
Berlin 5
Jining 5
Ningbo 5
Toronto 5
Falls Church 4
Hanover 4
Jinan 4
Auburn Hills 3
Munich 3
Redwood City 3
Rome 3
Taizhou 3
Zhengzhou 3
Blaubeuren 2
Borås 2
Changchun 2
Dong Ket 2
Espoo 2
Foshan 2
Fuzhou 2
Hamburg 2
Houston 2
Konstanz 2
Leawood 2
Lippstadt 2
Monmouth Junction 2
Nürnberg 2
Paris 2
Pavia 2
Pune 2
Radomsko 2
San Francisco 2
Tokyo 2
Torino 2
Veles 2
Amsterdam 1
Bangalore 1
Brno 1
Brooklyn 1
Cattolica 1
Cedar Knolls 1
Cinisello Balsamo 1
Clifton 1
Cologne 1
Corsico 1
Dallas 1
Falkenstein 1
Fayetteville 1
Gravina In Puglia 1
Guangzhou 1
Hanoi 1
Harbin 1
Hong Kong 1
Jiangmen 1
Kiel 1
London 1
Mannheim 1
Mashhad 1
Muscat 1
Novara 1
Orange 1
Perugia 1
Ponte Vedra Beach 1
Totale 2.617
Nome #
Biomedical and functional changes in bronchoalveolar parameters induced by ambroxol treatment of chronic bronchitis 212
Familial elevation of serum angiotensin converting enzyme activity. 90
Long-term effects of pulmonary andoarterectomy on cardioplmonary function and exercise tolerance 83
Assessment of emphysema in COPD. A functional and radiologic study 76
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 76
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 75
Long-term outcome after pulmonary endarterectomy. 74
Emergence of new pneumonia: besides severe acute respiratory syndrome 73
Studies of MR 889, a new synthetic proteinase inhibitor. 73
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 72
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 71
Acebrophylline: an airway mucoregulator and anti-inflammatory agent. 71
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. 69
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 69
Expression of receptor for advanced glycation end products in sarcoid granulomas. 69
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 69
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 67
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 67
Dai chinoloni ai fluorochinoloni respiratori 66
Chronic productive cough in young adults is very often due to chronic rhino-sinusitis 65
"Nonobstructive" emphysema of the lung 64
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 62
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 62
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 61
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. 60
Long-term clinical and cardiopulmonary effects of pulmonary endarteriectomy (PEA) 60
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 59
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 59
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 58
Depression after lung transplantation: causes and treatment 58
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 58
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 57
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 57
In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation. 56
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 56
Followup a lungo termine di pazienti affetti da ieprtensione polmonare cronica tromboembolica sottoposti ad endoarteriectomia polmonare 55
Nod2/CARD15 gene polymorphism in idiopathic pulmonary fibrosis 54
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. 53
RAGE receptor: a novel pro-inflammatory pathway for chronic respiratory disorders? 52
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 52
Primary lung adenocarcinoma: characteristics by smoking habit and sex. 52
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 52
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 51
Long-term effects of pulmonary endarterectomy (PEA) on clinical and cardiopulmonary function status 51
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 48
Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency 47
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 47
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. 46
Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies. 46
Role of alveolar phospholipids in bleomycin-induced pulmonary fibrosis in the rat. 45
Plasmapheresis for treatment of pulmonary alveolar proteinosis. 45
Synchronous lung cancers: when same histological types feature different molecular profiles and response phenotypes. 43
SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase. 42
What defines airflow obstruction in asthma? 42
Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. 40
Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies. 39
PERCUTANEOUS COMPUTED TOMOGRAPHY-GUIDED RADIOFREQUENCY THERMAL ABLATION OF SMALL UNRESECTABLE LUNG TUMOURS. 37
Relationship between changes in alveolar surfactant levels and lung defence mechanisms. 34
null 33
Sputum levels of eriythromycin after rectal administration in adult patients with bronchitis. 32
Interstitial pneumopathy and low-dosage amiodarone. 31
Long-term outcome after pulmonary endarterectomy 30
Complement receptor 1 gene polymorphisms in sarcoidosis. 4
Totale 3.677
Categoria #
all - tutte 14.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020288 0 0 0 0 0 55 22 59 5 83 63 1
2020/2021480 57 43 15 51 2 61 4 88 11 70 63 15
2021/2022253 10 3 8 3 7 6 7 17 15 5 46 126
2022/2023951 109 72 10 77 102 94 1 49 411 6 15 5
2023/2024409 47 70 10 18 42 83 3 52 4 16 55 9
2024/2025173 40 67 19 38 9 0 0 0 0 0 0 0
Totale 3.677